Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)NewsBilanz/GuVDividende/HVZertifikateDepot/Watchlist
Times + SalesChart-AnalyseAnalysenSchätzungenTermineOptionsscheinemyHome
BörsenplätzeChartvergleichKurszieleVergleichProfilKnock-OutsSenden
OrderbuchRealtime StuttgartFundamentalanalyseRatingInsidertradesFondsInvestmentreport
HistorischRealtime PushmyNews im ForumAnleihen
Kaufen
Verkaufen

Gilead Sciences News

  • Sprache:
  • Alle
  • DE
  • EN
  • Sortieren:
  • Datum
  • meistgelesen
07:45 Uhr
Gilead Sciences, Merck & Co., Pfizer, Twitter: Diese Zahlen könnten Sie erwarten (Die Börsenblogger)
27.07.15
Gilead Sciences: Sure, It's Hep-C But It's Not Just Hep-C (EN, The Wall Street Journal Deutschland)
27.07.15
Gilead Sciences: Sure, It’s Hep-C But It’s Not Just Hep-C (EN, Barrons)
27.07.15
Gilead Can Soothe Biotech Investor Fears with Great 2Q Earnings (EN, TheStreet.com)
24.07.15
Gilead Sciences: Still Plenty of Growth Despite 'Stagnated' Hepatitis-C (EN, The Wall Street Journal Deutschland)
24.07.15
Gilead Sciences: Still Plenty of Growth Despite ‘Stagnated’ Hepatitis-C (EN, Barrons)
24.07.15
What to Expect From Gilead Sciences Inc.'s Q2 Results (EN, MotleyFool)
23.07.15
Bet on a Gilead Earnings Rally (EN, The Wall Street Journal Deutschland)
22.07.15
Gilead Sciences' Next Big Move May Not Be What You're Thinking (EN, MotleyFool)
20.07.15
Why Gilead Will Beat Earnings Forecasts (EN, The Wall Street Journal Deutschland)
20.07.15
Why Gilead Will Beat Earnings Forecasts (EN, Barrons)
17.07.15
Gilead Sciences: A Big Week? (EN, The Wall Street Journal Deutschland)
17.07.15
Gilead Sciences: A Big Week? (EN, Barrons)
16.07.15
Gilead Limits Enrollment in its Hep C Patient Program to Pressure Insurers (EN, The Wall Street Journal Deutschland)
15.07.15
Are Gilead Sciences, Inc.'s Expectations Too High for This Drug? (EN, MotleyFool)
13.07.15
Gilead Hep C Sales Under Investor Microscope as Earnings Near (EN, TheStreet.com)
10.07.15
Gilead Sciences: Hep-C Prescriptions Still Slowing (EN, The Wall Street Journal Deutschland)
10.07.15
Gilead Sciences: Hep-C Prescriptions Still Slowing (EN, Barrons)
09.07.15
Gilead Sciences: Four Reasons For Optimism (EN, Barrons)
09.07.15
Gilead Sciences: Four Reasons For Optimism (EN, The Wall Street Journal Deutschland)
07.07.15
Gilead Sciences Gets Another Green Light in Japan (EN, MotleyFool)
06.07.15
Gilead Sciences Spent $125 Million to Get This Drug on the Market 4 Months Early (EN, MotleyFool)
06.07.15
Gilead Sciences (GILD) Stock Gains as Japan Approves Harvoni Treatment (EN, TheStreet.com)
06.07.15
Gilead Sciences: Merrill Lynch Raises Target Price Still Rates Underperform (EN, The Wall Street Journal Deutschland)
06.07.15
Gilead Sciences: Merrill Lynch Raises Target Price Still Rates Underperform (EN, Barrons)
01.07.15
Is Gilead Just the First Biotech Stock to Sink? (EN, TheStreet.com)
01.07.15
Jim Cramer's Top Takeaways: Celgene, Gilead Sciences, Regeneron, Alarm.com, TransUnion (EN, TheStreet.com)
01.07.15
Adidas, Wacker Chemie, Gilead Sciences, Clariant, Templeton Growth, VStoxx (Börse Online)
01.07.15
Julian Robertson Really Likes Gilead Sciences (EN, Barrons)
01.07.15
Julian Robertson Really Likes Gilead Sciences (EN, The Wall Street Journal Deutschland)
29.06.15
Gilead Sciences (GILD) Stock Declines on Lawsuit Seeking Access to Clinical Trial Data (EN, TheStreet.com)
29.06.15
FDA is Sued by Advocacy Groups That Want Gilead Hepatitis C Trial Data (EN, The Wall Street Journal Deutschland)
26.06.15
Gilead Sciences: New Scripts for Harvoni/Sovaldi Decelerating (EN, The Wall Street Journal Deutschland)
26.06.15
Gilead Sciences: New Scripts for Harvoni/Sovaldi Decelerating (EN, Barrons)
24.06.15
Gilead Can Gallop Higher: Biotech Ace 'Breaking Out' (EN, The Wall Street Journal Deutschland)
21.06.15
Did China Just Crush Gilead Sciences' Dreams? (EN, MotleyFool)
19.06.15
Gilead Sciences: New Harvoni Prescriptions Decelerate (EN, Barrons)
19.06.15
Gilead Sciences: New Harvoni Prescriptions Decelerate (EN, The Wall Street Journal Deutschland)
19.06.15
Gilead Patent for its Sovaldi Hep C Drug is Rejected by Chinese Authorities (EN, The Wall Street Journal Deutschland)
19.06.15
Gilead Sciences (GILD) Stock Declines as China Rejects Sovaldi Patent Application (EN, TheStreet.com)
Seite: 123456789...22

Gilead Sciences News

Gilead Sciences News: auf dieser Seite finden Sie alle Gilead Sciences News und Nachrichten zur Gilead Sciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Gilead Sciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Gilead Sciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.